Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33


Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.

Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group.

N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513.


New occurrence of reed bed decline in southern Europe: do permanent flooding and chemical parameters play a role?

Gigante D, Angiolini C, Landucci F, Maneli F, Nisi B, Vaselli O, Venanzoni R, Lastrucci L.

C R Biol. 2014 Jul-Aug;337(7-8):487-98. doi: 10.1016/j.crvi.2014.05.005. Epub 2014 Jul 2.


Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.

Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, De Tursi M, Grassadonia A, Mazzilli L, Iacobelli S, Gamucci T, Vici P; “FOLLOW-UP” Study Group.

PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014.


Severe thrombocytopenia after trastuzumab retreatment: a case report.

Pino MS, Angiolini C, Fioretto L.

BMC Res Notes. 2013 Oct 4;6:400. doi: 10.1186/1756-0500-6-400.


Distribution of endemic and alien plants along Mediterranean rivers: a useful tool to identify areas in need of protection?

Angiolini C, Nucci A, Landi M, Bacchetta G.

C R Biol. 2013 Aug;336(8):416-23. doi: 10.1016/j.crvi.2013.07.001. Epub 2013 Aug 22.


Comparing cancer care, outcomes, and costs across health systems: charting the course.

Lipscomb J, Yabroff KR, Hornbrook MC, Gigli A, Francisci S, Krahn M, Gatta G, Trama A, Ritzwoller DP, Durand-Zaleski I, Salloum R, Chawla N, Angiolini C, Crocetti E, Giusti F, Guzzinati S, Mezzetti M, Miccinesi G, Mariotto A.

J Natl Cancer Inst Monogr. 2013;2013(46):124-30. doi: 10.1093/jncimonographs/lgt011. No abstract available.


Initial treatment for newly diagnosed elderly colorectal cancer patients: patterns of care in Italy and the United States.

Gigli A, Warren JL, Yabroff KR, Francisci S, Stedman M, Guzzinati S, Giusti F, Miccinesi G, Crocetti E, Angiolini C, Mariotto A.

J Natl Cancer Inst Monogr. 2013;2013(46):88-98. doi: 10.1093/jncimonographs/lgt006.


Cost profiles of colorectal cancer patients in Italy based on individual patterns of care.

Francisci S, Guzzinati S, Mezzetti M, Crocetti E, Giusti F, Miccinesi G, Paci E, Angiolini C, Gigli A.

BMC Cancer. 2013 Jul 5;13:329. doi: 10.1186/1471-2407-13-329.


Feasibility of evaluating quality cancer care using registry data and electronic health records: a population-based study.

Caldarella A, Amunni G, Angiolini C, Crocetti E, Di Costanzo F, Di Leo A, Giusti F, Pegna AL, Mantellini P, Luzzatto L, Paci E.

Int J Qual Health Care. 2012 Aug;24(4):411-8. doi: 10.1093/intqhc/mzs020. Epub 2012 May 16.


Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group.

N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7.


CORINE land cover and floristic variation in a Mediterranean wetland.

Giallonardo T, Landi M, Frignani F, Geri F, Lastrucci L, Angiolini C.

Environ Monit Assess. 2011 Nov;182(1-4):141-54. doi: 10.1007/s10661-010-1865-x. Epub 2011 Jan 13.


Genomic matrix attachment region and chromosome conformation capture quantitative real time PCR assays identify novel putative regulatory elements at the imprinted Dlk1/Gtl2 locus.

Braem C, Recolin B, Rancourt RC, Angiolini C, Barthès P, Branchu P, Court F, Cathala G, Ferguson-Smith AC, Forné T.

J Biol Chem. 2008 Jul 4;283(27):18612-20. doi: 10.1074/jbc.M801883200. Epub 2008 May 5.


[The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Hormone therapy: what kind of evidence?].

Angiolini C.

Suppl Tumori. 2004 Jul-Aug;3(4):S75-6. Review. Italian. No abstract available.


Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.

Venturini M, Del Mastro L, Garrone O, Angiolini C, Merlano M, Bergaglio M, Tolino G, Lambiase A, Baldini A, Canavese G, Rosso R.

Ann Oncol. 2002 Apr;13(4):546-52.


Toremifene as a substitute for adjuvant tamoxifen in breast cancer patients.

Bertelli G, Queirolo P, Vecchio S, Angiolini C, Bergaglio M, Del Mastro L, Signorini A, Valenzano M, Venturini M.

Anticancer Res. 2000 Sep-Oct;20(5C):3659-61.


Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.

Bertelli G, Valenzano M, Costantini S, Rissone R, Angiolini C, Signorini A, Gustavino C.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):275-7.


Inhibitory effects of human neutrophil functions by the 45-kD glycoprotein derived from the parasitic nematode Trichinella spiralis.

Bruschi F, Carulli G, Azzarà A, Homan W, Minnucci S, Rizzuti-Gullaci A, Sbrana S, Angiolini C.

Int Arch Allergy Immunol. 2000 May;122(1):58-65.


Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.

Venturini M, Lunardi G, Del Mastro L, Vannozzi MO, Tolino G, Numico G, Viale M, Pastrone I, Angiolini C, Bertelli G, Straneo M, Rosso R, Esposito M.

J Clin Oncol. 2000 May;18(10):2116-25.


Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients.

Esposito M, Venturini M, Vannozzi MO, Tolino G, Lunardi G, Garrone O, Angiolini C, Viale M, Bergaglio M, Del Mastro L, Rosso R.

J Clin Oncol. 1999 Apr;17(4):1132.


Detection of eosinophils in whole blood samples by flow cytometry.

Carulli G, Sbrana S, Azzarà A, Minnucci S, Angiolini C, Marini A, Ambrogi F.

Cytometry. 1998 Dec 15;34(6):272-9.


Supplemental Content

Loading ...
Support Center